China's WuXi weighs sale of pharma operations as US restrictions loom

China's WuXi weighs sale of pharma operations as US restrictions loom

FILE PHOTO: The logo of Chinese drug research and development group WuXi AppTec is displayed alongside its company website, in this illustration picture taken February 5, 2024. REUTERS/Florence Lo/Illustration/File Photo

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter